PRPO

Precipio Inc

22.13

Nov 13 • 3:59 PM ET -1.12 (-4.82%)

22.10

Aftermarket • 7:30 PM ET -0.03 (-0.14%)

Healthcare Diagnostics & Research USA Nano NASD

Peers: NEO MDXH QGEN BNGO IMDX BDSX XGN VCYT CSTL PSNL

| Held by: VTI VXF IWC DFMC DFAS DFSU DCOR DFAC DXUV

Scroll to Statements

Index	-
Market Cap	39.68M
Enterprise Value	39.79M
Income	-1.14M
Sales	27.76M
Book/sh	8.29
Cash/sh	2.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	61
IPO	Jul 18, 2000

P/E	-
Forward P/E	-
PEG	-
P/S	1.43
P/B	2.67
P/C	11.08
P/FCF	28.55
EV/EBITDA	97.05
EV/Sales	1.43
Quick Ratio	1.54
Current Ratio	1.77
Debt/Eq	0.25
LT Debt/Eq	0.19
Option/Short	No / Yes

EPS (ttm)	-0.64
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	72.37% 57.83%
Sales past 3/5Y	36.71% 31.60%
EPS Y/Y TTM	22.97%
Sales Y/Y TTM	21.76%
EPS Q/Q	90.66%
Sales Q/Q	8.33%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	- -

Insider Own	12.57%
Insider Trans	-1.76%
Inst Own	18.69%
Inst Trans	0.96%
ROA	-5.34%
ROE	-8.00%
ROIC	-6.45%
Gross Margin	37.74%
Oper. Margin	-5.34%
Profit Margin	-4.12%
SMA20	8.19%
SMA50	-3.65%
SMA200	-10.82%
Trades

Shs Outstand	1.79M
Shs Float	1.57M
Short Float	3.50%
Short Ratio	0.57
Short Interest	0.05M
52W High	33.63 -34.20%
52W Low	17.79 24.40%
Volatility	11.75% 7.07%
ATR (14)	1.65
RSI (14)	52.48
Beta	1.42
Rel Volume	0.15
Avg Volume	96.90K
Volume	14,715

Perf Week	18.85%
Perf Month	-1.82%
Perf Quarter	-7.41%
Perf Half Y	-15.02%
Perf YTD	-3.70%
Perf Year	13.37%
Perf 3Y	180.48%
Perf 5Y	-52.31%
Perf 10Y	-98.71%
Recom	1.00
Target Price	19.00
Prev Close	23.25
Price	22.13
Change %	-4.82%

Nov-11-26 01:21PM	Precipio Announces Q3-2026 Financial Results (InvestorsHub)
Nov-10-26 04:15PM	Precipio Announces Q3-2026 Financial Results (GlobeNewswire) +6.53%
Oct-29-26 01:54PM	Precipio Announces Q3-2026 Shareholder Update Call (InvestorsHub)
Oct-28-26 05:00PM	Precipio Announces Q3-2026 Shareholder Update Call (GlobeNewswire)
Sep-10-26 04:12PM	Top Research Reports for Goldman Sachs, RTX & Abbott (Zacks) +5.12%
11:02PM	Loading…
Aug-20-26 11:02PM	Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ... (GuruFocus.com) +5.67%
Aug-14-26 04:00PM	Precipio Announces Q2-2026 Financial Results (GlobeNewswire)
Jul-31-26 04:00PM	Precipio Announces Q2-2026 Shareholder Update Call (GlobeNewswire)
Jun-12-26 01:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
Jun-11-26 05:00PM	Precipio to Present at the Planet MicroCap Las Vegas (GlobeNewswire)
May-20-26 09:01PM	Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges (GuruFocus.com)
May-14-26 05:00PM	Precipio Announces Q1 2026 Financial Results (GlobeNewswire) -8.95%
May-13-26 05:00PM	Management team's 2025 market-based Options have vested (GlobeNewswire)
May-11-26 05:17PM	B2i Digital Welcomes Precipio, Inc. as a New Featured Company (NewMediaWire)
May-06-26 05:00PM	Precipio Announces Q1-2026 Shareholder Update Call (GlobeNewswire) -7.38%
05:00PM	Loading…
Mar-12-26 05:00PM	Precipio Announces Q4 and year-end 2025 Shareholder Update Call (GlobeNewswire) -6.66%
Mar-10-26 09:00AM	Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay (GlobeNewswire)
Feb-25-26 09:30AM	Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year (GlobeNewswire)
Jan-15-26 09:00AM	Precipio Takes Major Steps Toward a Clean Balance Sheet (GlobeNewswire)
Dec-26-25 01:53AM	The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio (Zacks)
Dec-24-25 01:10PM	Top Stock Reports for AbbVie, Coca-Cola & Chevron (Zacks)
Dec-05-25 10:00AM	Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting (GlobeNewswire)
Dec-04-25 08:00AM	Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact (GlobeNewswire)
Nov-19-25 11:34AM	Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow (Zacks) +12.28%
Nov-18-25 12:01AM	Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +11.17%
Nov-14-25 04:30PM	Precipio Announces its Q3-2025 Financial Results (GlobeNewswire) +8.79%
Nov-04-25 05:00PM	Precipio Announces Q3-2025 Shareholder Update Call (GlobeNewswire)
Sep-23-25 11:58AM	The Zacks Analyst Blog Highlights HSBC, American Express, TotalEnergies, Armanino Foods of Distinction and Precipio (Zacks)
Sep-22-25 04:10PM	Top Stock Reports for HSBC, American Express & TotalEnergies (Zacks)
Sep-02-25 10:00AM	Precipio Terminates Its ATM (GlobeNewswire)
05:00PM	Loading…
Aug-13-25 05:00PM	Precipio Announces its Q2-2025 Financial Results (GlobeNewswire)
Jul-31-25 04:30PM	Precipio Announces Q2-2025 Shareholder Update Call (GlobeNewswire)
Jul-11-25 04:30PM	Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless (GlobeNewswire)
Jul-08-25 12:02PM	Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipios the Buy. (Barchart) +13.16%
Jul-07-25 06:03AM	The Zacks Analyst Blog Highlights Apple, Oracle, Goldman Sachs and Precipio (Zacks) +16.02%
Jul-03-25 04:25PM	Top Research Reports for Apple, Oracle & Goldman Sachs (Zacks) +6.67%
Jun-16-25 12:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
May-16-25 05:01PM	Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... (GuruFocus.com) +10.21% +6.22%
May-14-25 05:00PM	Precipio Announces its Q1-2025 Financial Results (GlobeNewswire)
May-01-25 05:00PM	Precipio Announces Q1-2025 Shareholder Update Call (GlobeNewswire) +15.26%
Apr-22-25 08:59AM	The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio (Zacks)
Apr-21-25 04:49PM	Top Research Reports for Visa, ServiceNow & Progressive (Zacks) -10.88%
Apr-02-25 09:00AM	Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... (GuruFocus.com)
Mar-31-25 10:50PM	Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
Mar-17-25 05:00PM	Precipio Announces Q4 and year-end 2024 Shareholder Update Call (GlobeNewswire) +9.22% -8.06%
Feb-26-25 09:45AM	Precipio achieves positive adjusted EBITDA, cash flow in Q4 (TipRanks) -13.54%
Feb-25-25 09:30AM	Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) (GlobeNewswire) -12.69%
Jan-16-25 05:00PM	Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs (GlobeNewswire) +5.85%
Nov-20-24 08:00AM	Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... (GuruFocus.com)
Nov-06-24 05:00PM	Precipio Announces Q3-2024 Shareholder Update Call (GlobeNewswire)
Oct-08-24 10:00AM	Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping (GlobeNewswire)
Sep-06-24 04:00PM	Precipio Announces Employee Stock Option Plan Repricing (GlobeNewswire)
Aug-15-24 05:00PM	Precipio Announces Q2-2024 Shareholder Update Call (GlobeNewswire) +5.96%
Jul-25-24 09:00AM	Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven (GlobeNewswire) +8.01%
Jul-17-24 09:00AM	Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 (GlobeNewswire) +23.87%
Jun-13-24 04:00PM	Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-12-24 04:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
09:00AM	Precipio Provides Status Update on Current Business Matters (GlobeNewswire)
May-15-24 08:52AM	PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-06-24 05:00PM	Precipio Secures a short-term $500K Credit Facility (GlobeNewswire)
Apr-01-24 10:53AM	PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 05:00PM	Precipio Announces Year end 2023 Shareholder Update Call (GlobeNewswire)
Feb-13-24 10:00AM	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY (GlobeNewswire)
Feb-06-24 10:00AM	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer (GlobeNewswire) +8.24%
Jan-23-24 10:00AM	Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter (GlobeNewswire)
Jan-17-24 10:30AM	Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan (GlobeNewswire) +15.37%
Jan-02-24 09:00AM	Precipio Announces Christina Valauri joins the Board of Directors (GlobeNewswire)
Dec-14-23 04:30PM	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 (GlobeNewswire) +12.40%
Nov-16-23 05:00PM	Precipio Announces Q3-2023 Shareholder Update Call (GlobeNewswire) -7.74%
Oct-18-23 09:00AM	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 (GlobeNewswire)
Oct-03-23 10:00AM	Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 (GlobeNewswire)
Sep-28-23 09:00AM	Precipio Continues to Sign New HemeScreen Customers (GlobeNewswire)
Sep-25-23 11:00AM	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven (GlobeNewswire)
Sep-21-23 09:00AM	Precipio Takes Final Step Towards Regaining Nasdaq Compliance (GlobeNewswire) -10.41%
Sep-13-23 09:30AM	Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan (GlobeNewswire) +7.80%
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-19-23 06:01AM	Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 10:16AM	Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story (Simply Wall St.)
Aug-10-23 05:00PM	Precipio Announces Q2-2023 Shareholder Update Call (GlobeNewswire)
Aug-08-23 09:00AM	Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel (GlobeNewswire)
Aug-03-23 09:00AM	Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven (GlobeNewswire)
Aug-01-23 09:00AM	Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023 (GlobeNewswire) +5.74%
Jun-14-23 09:49AM	Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy (GlobeNewswire)
Jun-13-23 09:00AM	Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology (GlobeNewswire)
Jun-08-23 08:30AM	Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -29.40%
Jun-07-23 09:30AM	Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects (GlobeNewswire) +15.23%
May-22-23 11:00AM	Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology (GlobeNewswire)
May-17-23 04:00PM	Precipio Shares Growth Catalysts For HemeScreen (GlobeNewswire)
May-15-23 04:00PM	Precipio Announces Q1-2023 Shareholder Update Call (GlobeNewswire)
May-04-23 01:00PM	Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division (GlobeNewswire) -6.71%
10:00AM	Precipio Signs Another HemeScreen Customer (GlobeNewswire)
Apr-27-23 05:00PM	Precipio Granted 180-day Extension From NASDAQ To Regain Compliance (GlobeNewswire)
Apr-19-23 11:00AM	Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined (GlobeNewswire)
Apr-09-23 10:25AM	Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-02-23 08:55AM	Precipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021) (Simply Wall St.)
Mar-28-23 05:00PM	Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-23 10:30AM	Precipio Ships First IV-Cell® Order to Major US Healthcare System (GlobeNewswire)
Mar-07-23 12:49PM	CORRECTION -- Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
12:00PM	Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
Feb-14-23 11:44AM	ThermoFisher Salesforce Votes Precipios HemeScreen® as Best New Product (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SANDBERG RICHARD A	Director	May 21 '26	Sale	25.02	900	22,517	3,000	May 26 04:00 PM
SANDBERG RICHARD A	Director	May 20 '26	Sale	24.89	2,034	50,632	8,142	May 21 04:00 PM
SANDBERG RICHARD A	Director	May 19 '26	Sale	24.42	600	14,652	4,400	May 21 04:00 PM
SANDBERG RICHARD A	Director	May 20 '26	Sale	25.00	500	12,500	3,900	May 21 04:00 PM
SANDBERG RICHARD A	Director	May 19 '26	Proposed Sale	24.85	4,034	100,245		May 19 02:19 PM
Sabet Ahmed Zaki	Chief Operating Officer	Apr 01 '26	Buy	27.93	19	531	1,034	Apr 10 04:00 PM
Sabet Ahmed Zaki	Chief Operating Officer	Jan 02 '26	Buy	23.40	20	468	735	Jan 06 04:34 PM

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

FounderMr. Ilan Danieli

Chief Operating OfficerMr. Ahmed Zaki Sabet

Chief Technology OfficerDr. Ayman A. Mohamed M.D.

Chief Financial OfficerMr. Matthew Gage

Chief Legal Counsel & People OfficerMs. Miri Chiko-Radomski

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

PRPO

Precipio Inc

Upgrade your Finviz experience

All the Features.
Half the Price.